jim cramer weighs the market impact of eli lilly and novo nordisk's weight loss drugs
Published 1 year ago • 18K plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
2:49
jim cramer explains why he favors eli lilly in the weight loss drug space
-
10:43
jim cramer digs into nvidia's 'preposterously great' earnings
-
2:55
eli lilly's experimental obesity drug could be 'revolutionary,' says jim cramer
-
9:38
jim cramer goes off the charts with the impact of trump tariffs
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
4:50
lightning round: pepsico is difficult position right now, says jim cramer
-
5:22
eii lilly's weight-loss drug is 'much better' than others on the market, says wells fargo's bansal
-
10:23
gaetz says he’s not returning to congress next year
-
18:21
making the case for trump’s tariffs | amanpour and company
-
10:06
20% to 30% pullback will counter "sugar high" market
-
5:06
eli lilly and novo can 'coexist for awhile' in the weight-loss drug space, says bmo's evan seigerman
-
11:28
we stuck with eli lilly because we did the homework, says jim cramer
-
8:05
e.l.f beauty ceo tarang amin goes one-on-one with jim cramer
-
2:02
jim cramer explains why eli lilly will be the winner over biogen in alzheimer's fight
-
4:21
eli lilly's weight-loss drug could be the best selling drug of all time, says jim cramer
-
0:41
jim cramer on the huge potential for eli lilly's answer to ozempic #shorts
-
3:07
jim cramer: eli lilly stock represents real value
-
9:35
eli lilly's miss explanation is 'totally opaque', says jim cramer
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
3:24
eli lilly and novo nordisk will remain winners in the weight-loss category: barclays' emily field
-
1:15
why jim cramer thinks investors should buy eli lilly on the dip
-
1:52
cramer’s mad dash: eli lilly